loadpatents
Patent applications and USPTO patent grants for GAZZARD; Lewis J..The latest application filed is for "tetracyclic oxazepine compounds and uses thereof".
Patent | Date |
---|---|
Tetracyclic Oxazepine Compounds And Uses Thereof App 20220281893 - GAZZARD; Lewis J. ;   et al. | 2022-09-08 |
Inhibitors Of Iap App 20220211797 - COHEN; Frederick ;   et al. | 2022-07-07 |
Cinnoline Compounds And Uses Thereof App 20220073520 - Malhotra; Sushant ;   et al. | 2022-03-10 |
(4-hydroxypyrrolidin-2-yl)-heterocyclic compounds and methods of use thereof Grant 11,242,344 - Blaquiere , et al. February 8, 2 | 2022-02-08 |
Isoquinoline Compounds For The Treatment Of Cancer App 20210332064 - Liang; Jun ;   et al. | 2021-10-28 |
(4-hydroxypyrrolidin-2-yl)-heterocyclic Compounds And Methods Of Use Thereof App 20210309660 - Blaquiere; Nicole ;   et al. | 2021-10-07 |
Naphthyridine Compounds And Uses Thereof App 20210277024 - Kellar; Terry ;   et al. | 2021-09-09 |
Inhibitors of IAP Grant 11,096,982 - Cohen , et al. August 24, 2 | 2021-08-24 |
Isoquinoline Compounds And Uses Thereof App 20210253580 - Liang; Jun ;   et al. | 2021-08-19 |
Tert-butyl (s)-2-(4-(phenyl)-6h-thieno[3, 2-f][1, 2, 4]triazolo[4, 3-a] [1,4]diazepin-6-yl) Acetate Derivatives And Related Compounds As Bromodomain Brd4 Inhibitors For Treating Cancer App 20210221821 - BLAKE; Robert Anthony ;   et al. | 2021-07-22 |
8-aminoisoquinoline Compounds And Uses Thereof App 20200108075 - LIANG; Jun ;   et al. | 2020-04-09 |
Inhibitors Of Iap App 20190224269 - Cohen; Frederick ;   et al. | 2019-07-25 |
Inhibitors Of Iap App 20170136084 - COHEN; Frederick ;   et al. | 2017-05-18 |
Inhibitors of IAP Grant 9,586,991 - Cohen , et al. March 7, 2 | 2017-03-07 |
Inhibitors Of Iap App 20160102119 - COHEN; Frederick ;   et al. | 2016-04-14 |
Substituted 6,6-Fused Nitrogenous Heterocyclic Compounds and Uses Thereof App 20160060262 - Lyssikatos; Joseph P. ;   et al. | 2016-03-03 |
Inhibitors of IAP Grant 9,238,675 - Cohen , et al. January 19, 2 | 2016-01-19 |
Diazacarbazoles And Methods Of Use App 20150368244 - Dyke; Hazel Joan ;   et al. | 2015-12-24 |
Methods of use of diazacarbazoles for treating cancer Grant 9,216,980 - Chen , et al. December 22, 2 | 2015-12-22 |
Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof Grant 9,206,175 - Lyssikatos , et al. December 8, 2 | 2015-12-08 |
Inhibitors of IAP Grant 8,980,837 - Cohen , et al. March 17, 2 | 2015-03-17 |
Serine/threonine Kinase Inhibitors App 20150031674 - Rudolph; Joachim ;   et al. | 2015-01-29 |
Inhibitors of IAP Grant 8,907,092 - Flygare , et al. December 9, 2 | 2014-12-09 |
Inhibitors Of Iap App 20140235551 - COHEN; Frederick ;   et al. | 2014-08-21 |
Inhibitors of IAP Grant 8,716,236 - Cohen , et al. May 6, 2 | 2014-05-06 |
Substituted 6,6-fused Nitrogenous Heterocyclic Compounds And Uses Thereof App 20140088076 - Lyssikatos; Joseph P. ;   et al. | 2014-03-27 |
Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof Grant 8,623,889 - Lyssikatos , et al. January 7, 2 | 2014-01-07 |
Methods Of Use Of Diazacarbazoles For Treating Cancer App 20130261104 - Chen; Huifen ;   et al. | 2013-10-03 |
Diazacarbazoles and methods of use Grant 8,501,765 - Chen , et al. August 6, 2 | 2013-08-06 |
Inhibitors Of Iap App 20130172264 - COHEN; Frederick ;   et al. | 2013-07-04 |
Substituted pyrroles and methods of use Grant 8,410,279 - Gazzard , et al. April 2, 2 | 2013-04-02 |
Substituted 6,6-fused Nitrogenous Heterocyclic Compounds And Uses Thereof App 20120322785 - Lyssikatos; Joseph P. ;   et al. | 2012-12-20 |
Inhibitors Of Iap App 20120202750 - Cohen; Frederick ;   et al. | 2012-08-09 |
Inhibitors of IAP Grant 8,110,568 - Cohen , et al. February 7, 2 | 2012-02-07 |
Diazacarbazoles And Methods Of Use App 20110124654 - Chen; Huifen ;   et al. | 2011-05-26 |
Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use Grant 7,947,839 - Gazzard , et al. May 24, 2 | 2011-05-24 |
Substituted Pyrroles And Methods Of Use App 20110118320 - Gazzard; Lewis J. ;   et al. | 2011-05-19 |
Diazacarbazoles And Methods Of Use App 20110118230 - Chen; Huifen ;   et al. | 2011-05-19 |
Inhibitors Of Iap App 20110077265 - Flygare; John A. ;   et al. | 2011-03-31 |
Inhibitors Of Iap App 20100256115 - Cohen; Frederick ;   et al. | 2010-10-07 |
Inhibitors of IAP App 20070299052 - Cohen; Frederick ;   et al. | 2007-12-27 |
Acylsulfamide inhibitors of factor VIIa Grant 7,250,447 - Rawson , et al. July 31, 2 | 2007-07-31 |
Inhibitors of IAP Grant 7,244,851 - Cohen , et al. July 17, 2 | 2007-07-17 |
Antibody drug conjugates and methods App 20070134243 - Gazzard; Lewis J. ;   et al. | 2007-06-14 |
ACYLSULFAMIDE INHIBITORS OF FACTOR VIIa App 20070037814 - Rawson; Thomas E. ;   et al. | 2007-02-15 |
Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use App 20060182751 - Gazzard; Lewis J. ;   et al. | 2006-08-17 |
Inhibitors of IAP App 20060014700 - Cohen; Frederick ;   et al. | 2006-01-19 |
Acylsulfamide inhibitors of factor VIIa App 20040242585 - Rawson, Thomas E. ;   et al. | 2004-12-02 |
Caspase activivated prodrugs therapy App 20040052793 - Carter, Paul J. ;   et al. | 2004-03-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.